The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
2012 · Archives of General Psychiatry · 944 citations
https://doi.org/10.1001/archgenpsychiatry.2012.169
M
Mark Slifstein
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.7K
Papers
16.2K
Citations
65
h-index
138
i10-index
Mark Slifstein is an academic researcher from Stony Brook School. The author has contributed to research in topics: Neurotransmitter Receptor Influence on Behavior & Schizophrenia research and treatment & Functional Brain Connectivity Studies. The author has an h-index of 65, co-authored 1434 publications.
ORCID: 0000-0003-2142-6353Papers by this author
worksPathway-Specific Dopamine Abnormalities in Schizophrenia
2016 · Biological Psychiatry · 293 citations
https://doi.org/10.1016/j.biopsych.2016.03.2104
Baseline reward processing and ventrostriatal dopamine function are associated with pramipexole response in depression
2020 · Brain · 96 citations
https://doi.org/10.1093/brain/awaa002
Response of Cortical Metabolic Deficits to Serotonergic Challenge in Familial Mood Disorders
2002 · American Journal of Psychiatry · 58 citations
https://doi.org/10.1176/appi.ajp.160.1.76
A role for foregut tyrosine metabolism in glucose tolerance
2019 · Molecular Metabolism · 38 citations
https://doi.org/10.1016/j.molmet.2019.02.008
Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [11C]-(+)-PHNO Positron Emission Tomography and Functional Magnetic Resonance Imaging Study
2018 · Biological Psychiatry · 35 citations
https://doi.org/10.1016/j.biopsych.2018.05.014
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat